Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Job title: Interventional Cardiologist
DrGasparini is an Interventional Cardiologist atHumanitas Research Hospital, Italy. He is specialized in treatment of complex coronary artery disease, such as chronic total occlusions, saphenous vein grafts, bifurcations, left main disease and in management of complications.He is CTO operator, proctor and educator. He is the Founder and Course Director of the CTO Live Aid event. Dr… View more
TCT 2018: SYNTAXES
Author(s): Daniel JFM Thuijs Added: 5 years ago
Dr Daniel J.F.M Thuijs (Erasmus Mc University Rotterdam, NL) discusses SYNTAXES - Ten-year follow up from a randomised trial of drug-eluting stents vs bypass surgery in patients with left main and triple vessel disease (preliminary results). Filmed by Radcliffe Cardiology on site at TCT 2018. View more

Vascular Disease and Surgery

Intervention
Foreword

Article

Author(s): Karen R Lui Added: 3 years ago
TodayÔÇÖs medical professional hardly goes a day without reading about or discussing the topic of 'disease managementÔÇÖ. While the term 'secondary preventionÔÇÖ has been around much longer, the newly emerging term refers to managing the chronic illness of large populations. The implications of this rapidly growing strategy are great for the future delivery of secondary prevention services to… View more

Heart Failure
Type and Duration of Antithrombotic Treatment in Complex PCI
Author(s): Despoina-Rafailia Benetou , Charalampos Varlamos , Christos Pappas , et al Added: 2 years ago

Anticoagulation
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB
Author(s): Rafael Romaguera Added: 2 years ago
In this short interview, Dr Rafael Romaguera (University of Barcelona, SP) discusses the findings from the SUGAR trial.This randomized head-to-head trial aimed to compare Cre8 EVO stents to a contemporary drug-eluting stent (DES) in patients with diabetes (DM) and coronary artery disease. The trial, first presented at TCT 2021, demonstrated that Cre8 EVO stents were non-inferior to Resolute Onyx… View more

Prevention & Chronic Conditions
ESC 2018: CAMELLIA-TIMI 61
Author(s): Erin A Bohula Added: 5 years ago
Dr Erin Bohula (Brigham and Women's Hospital, Boston, US) discusses CAMELLIA-TIMI 61 - a study to evaluate the effect of long-term treatment with BELVIQ (Lorcaserin HCl) on the incidence of MACE and conversion to type 2 diabetes mellitus in obese and overweight subjects with CVD or multiple CV risk factors. Filmed on-site at ESC 2018. View more

Prevention & Chronic Conditions
Research Area(s) / Expertise:
ACC 2020: PRONOMOS Trial - Rivaroxaban Versus Enoxaparin
Added: 3 years ago
Dr Nadia Rosencher and Dr Marc Samama (Hôpital Cochin, Paris, FR) discuss the PRONOMOS Trial (PROphylaxis in NOn Major Orthopaedic Surgery). Questions: 1. What was the rationale for the study? 2. Can you describe the aim, study design, endpoints and outcomes for this study? 3. What were the results? 4. What conclusions can be made from this data? 5. Which patient groups will benefit most from… View more

Vascular Disease and Surgery

Intervention